Navigation Links
New evidence highlights risk of comorbidities for COPD patients
Date:9/26/2011

toms were common in people who had both COPD and heart disease compared to people with normal lung function: 53% of people with COPD and heart disease had nasal symptoms compared to 35.8% in people with normal lung function and heart disease.

In addition, 62.2% of people with both restricted lung function and heart disease had nasal symptoms, demonstrating that the symptoms could be used as a marker for identifying increased risk of heart disease and COPD in people yet to be diagnosed with either condition.

Dr Anne Lindberg, from the Sunderby Hospital in Sweden, said: "Our findings are the first to shed light on the links between both nasal symptoms and cardiovascular condition, in relation to people with COPD and restrictive lung function. This has important implications for clinicians who need to understand the potential overlaps of these conditions when they are treating people with COPD. In addition to raising awareness of these co-morbidities, it will also be important to investigate these links further and look at the effect that co-morbid conditions have on exacerbations and disease progression. "

Professor Marc Decramer, President of the European Respiratory Society, said: "Clinicians often forget that people with one chronic condition usually have another illness at the same time. Many of the illnesses that are common alongside COPD, such as cardiovascular disease, may also share similar traits and it is vital that we build on research such as this study to identify new therapeutic targets in the future.

"The European Respiratory Roadmap, which was launched last month, outlines the need for great coordination between medical specialists. As the population is aging, the presence of co-morbidities will increase. The roadmap suggests that clinicians need to improve their recognition of other conditions to improve patient care and look at how to manage COPD in conjunction with other health conditions."


'/>"/>

Contact: Lauren Anderson
lauren.anderson@europeanlung.org
31-610-860-810
European Lung Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. More Evidence Links Diabetes, Dementia
2. NIH scientists find earliest known evidence of 1918 influenza pandemic
3. Evidence in the field of CVD in pregnancy is sparse, but the condition remains a concern:
4. Johns Hopkins Evidence-based Practice Center awarded $475,000 project
5. More Evidence That Alcohol Hinders Good Sleep
6. More Evidence Tanning Beds May Be Addictive
7. More Evidence That Exercise May Keep The Brain Sharp
8. Study shows new evidence of age-related decline in the brains master circadian clock
9. More Evidence That Early Treatment Can Stop HIVs Spread to Partners
10. More Evidence CT Scans Better at Detecting Lung Cancer
11. Little Evidence That Diet, Lifestyle Cuts Alzheimers Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published July ... of plastic surgery and explained why people should not shy away from their own ... excesses of the few and celebrate it for the modern wonder that it is.” ...
(Date:7/27/2015)... ... ... North Central Surgical Center Hospital will be holding twice-monthly joint wellness classes for ... along with their friends and family members, to attend. The classes take place on ... [Tue due to Labor Day], Oct 5, Nov 2, Dec 7) beginning at 9 ...
(Date:7/27/2015)... ... 27, 2015 , ... A Harris County jury awarded a group of Texas ... promoter Robert Kubbernus based on findings of fraud and violations of the Texas Securities ... court in Cause No. 2010-09675; Jo Ann Schermerhorn, et al v. CenturyLink, Inc. and ...
(Date:7/27/2015)... ... 2015 , ... BESLER Consulting today announced the publication of ... Medicare and Medicaid Services (CMS) provides each hospital affected by the HRRP with ... the QualityNet Hospital-Specific Report (HSR), this report contains a variety of insights that ...
(Date:7/27/2015)... ... 2015 , ... For a limited time, Huntington Beach dentist , Dr. ... a great time to change up a look or to simply brighten a smile. ... your self-esteem. Over time, the enamel coating can become worn and can expose more ...
Breaking Medicine News(10 mins):Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 3Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 4Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 5Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 6Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3
... are known to be good for lowering cholesterol and ... reported benefit: they appear to slow decline in lung ... According to researchers in Boston, it may be statins ... , Their findings were published in the second issue ...
... hire an ad agency; at,least not initially especially if you ... an agency can,t come up with something great. It,s,just that ... Most clients follow tradition process in attempting to find ... develop a,short list of 3 agencies and ask for a ...
... Educate Chicagoans, CHICAGO, Oct. 11 Continuing ... of Chicago, SAVE THE PATIENT, a,not-for-profit patient-focused organization, ... Chicago Access Network. "Community Health Hotline" will,air Monday, ... 21., Monday,s program will feature a frank ...
... /Xinhua-PRNewswire/ -- On,October 10, 2007, Synutra International, Inc. ... dairy-based nutritional products,for infants, children and adults, received ... the Company,s common stock is no longer subject ... October 5, 2007 of the,Company,s quarterly report on ...
... Monday will be a little,cooler for the patients ... the entire Washington Capitals team will make their annual,visit. ... raise money for,cancer research, Courage Caps., Courage Caps ... the season at Capitals home games and online at ...
... who overcome breast cancer have every reason to celebrate. ... a heart damaged by life-saving cancer therapies, a growing ... today including new treatments still under development ... Jones, Ph.D., an exercise physiologist and assistant professor in ...
Cached Medicine News:Health News:Statins reduce loss of function, keeping old lungs young - even in smokers 2Health News:A New Way to Discover Marketing Ideas 2Health News:Patient Empowerment -- Medication Error 2Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:Breast cancer awareness calls for cardiovascular awareness 2Health News:Breast cancer awareness calls for cardiovascular awareness 3
(Date:7/27/2015)... and PITTSBURGH , July 27, 2015 ... it will hold its extraordinary general meeting of shareholders in ... PRGO ; TASE) at the Okura Hotel Amsterdam on ... (CET). Among other agenda items at the ... the approval, under article 2:107a of the Dutch Civil Code, ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rq47bp/global_pressure ... Pressure Relief Devices Market 2015-2019" report to their ... to grow at a CAGR of 4.41% over the ... Market 2015-2019, has been prepared based on an in-depth ... covers the Americas, and the APAC and EMEA; it ...
(Date:7/27/2015)... PLEASANTON, Calif. , July 27, 2015  QT ... the "Group"), a global company engaged in the design, ... minimally invasive treatment of vascular disease, has entered into ... for up to US$13.14 million convertible bond investment. This ... help boost its growth to the next milestone. ...
Breaking Medicine Technology:Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3
... , SCOTTSDALE, Ariz. , Jan. 22 Matrixx Initiatives, ... financial results for the fiscal 2010 third quarter, ended December 31, ... January 25, 2010 . An earnings conference call will be held the ... AM ET . , To access the teleconference, please call (888) 452-4006 ...
... ... Called Ampyra, to Improve Walking for People With All Types of ... The U.S. Food and Drug Administration has approved the ... Therapeutics) for its ability to improve walking speed in people with ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 3Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 4Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 5Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 6
... For delivery of medication as well as ... refillable, closed dilution, high volume, continuous medication ... therapy to patients. Its 200 ml reservoir ... to 8 hours of nebulized medication delivery ...
Nebulizer Adapter Kit 6"...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: